Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug crawled time : 13:15 save search
Aldeyra Therapeutics Announces Completion of Enrollment in Phase 3 TRANQUILITY Trial in Patients with Dry Eye Disease and Reiterates New Drug Application (NDA) Submission Guidance
Published: 2021-11-09 (Crawled : 13:15) - biospace.com/
ALDX | News | $3.98 0.25% 0.5% 430K
|
Health Technology
|
| O: 1.11%
H: 3.41%
C: 1.76%
new drug dry eye disease eye application eye disease drug phase 3 trial submission enroll
Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic
Published: 2021-11-08 (Crawled : 13:15) - ir.hoththerapeutics.com
HOTH | $1.18 -4.06% 0.0% 20K
|
Health Technology
|
| O: -0.91%
H: 3.67%
C: 1.83%
cancer contract drug
Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica's Microbiome-Based Immuno-Oncology Drug
Published: 2021-10-27 (Crawled : 13:15) - biospace.com/
EVGN | $0.7 -13.64% 63K
|
Health Technology
|
| O: 1.15%
H: 1.13%
C: -3.77%
drug trial
All Endpoints Met in Hepion Pharmaceuticals’ Drug-Drug Interaction Study with CRV431
Published: 2021-09-29 (Crawled : 13:15) - globenewswire.com
HEPA | $2.1118 -0.85% -1.43% 30K
|
Health Technology
|
| O: 7.74%
H: 0.0%
C: -7.78%
drug crv431
Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Company’s Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage
Published: 2021-09-27 (Crawled : 13:15) - globenewswire.com
ACST | $3.07 -3.76% -3.91% 9.7K
|
Health Technology
|
| O: 0.0%
H: 5.31%
C: 0.88%
treatment drug
Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India
Published: 2021-09-21 (Crawled : 13:15) - prnewswire.com
AMPE | $0.242 -3.2% 0.0% 15K
|
Health Technology
|
| O: 1.22%
H: 4.82%
C: 4.22%
india drug approval
Onconova Therapeutics Announces Upcoming Presentation at the 3rd Annual RAS Targeted Drug Development Summit
Published: 2021-09-20 (Crawled : 13:15) - globenewswire.com
ONTX | $0.9953 -5.61% 1.3M
|
Health Technology
|
| O: -4.11%
H: 2.04%
C: -3.67%
presentation drug
Herpes Zoster (Shingles) Pipeline Drugs Guide 2021
Published: 2021-09-08 (Crawled : 13:15) - prnewswire.com
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -1.17%
H: 0.43%
C: 0.15%
drug herpes zoster
U.S. FDA Accepts for Priority Review Supplemental New Drug Application for Oxbryta® (voxelotor) for the Treatment of Sickle Cell Disease in Children Ages 4 to 11
Published: 2021-09-07 (Crawled : 13:15) - biospace.com/
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 1.23%
H: 1.51%
C: -2.39%
new drug disease treatment fda oxbryta children drug fda acceptance
GoodRx Announces Agreement with Surescripts to Provide Real-Time Drug Discount Pricing in Electronic Health Records
Published: 2021-08-05 (Crawled : 13:15) - globenewswire.com
GDRX 4 | $6.73 3.54% 3.49% 590K
|
Technology Services
|
| O: -0.76%
H: 1.6%
C: 0.63%
drug health
EOM Pharmaceuticals Appoints Drug Development Veteran Frank L. Douglas, Ph.D., M.D., Scientific Advisor
Published: 2021-07-22 (Crawled : 13:15) - biospace.com/
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.45%
H: 0.12%
C: -0.6%
drug
Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021
Published: 2021-06-14 (Crawled : 13:15) - biospace.com/
TMO | News | $541.52 -1.05% -0.1% 1.8M
|
Health Technology
|
| O: -0.1%
H: 1.34%
C: 1.16%
drug preclinical pre-clinical
Sorrento Announces Clinical Research Agreement With Mayo Clinic and FDA Clearance for the First Phase 1b Pilot Study Using Sofusa Lymphatic Drug Delivery Technology to Deliver Ipilimumab in Patients With Melanoma
Published: 2021-06-11 (Crawled : 13:15) - globenewswire.com
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 0.92%
H: 2.5%
C: 0.68%
fda clearance fda phase 1 drug research technology drug delivery liver phase 1b clearance phase 2b
Argenx Regains Rights to Blood Cancer Drug Following Dropped $1.6 Billion Deal
Published: 2021-06-08 (Crawled : 13:15) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.27%
H: 0.23%
C: -1.14%
blood drop cancer drug
INmune Bio, Inc. Announces Lead Drug Candidate XPro1595 Receives Chemical Drug Name pegipanermin from USAN
Published: 2021-06-02 (Crawled : 13:15) - globenewswire.com
INMB | $8.8 4.39% 4.1% 98K
|
Health Technology
|
| O: 2.08%
H: 2.36%
C: -2.51%
drug
Marijuana Workforce Drug Test Positivity Continues Double-Digit Increases to Keep Overall Drug Positivity Rates at Historically High Levels, Finds Latest Quest Diagnostics Drug Testing Index™ Analysis
Published: 2021-05-26 (Crawled : 13:15) - prnewswire.com
DGX | $125.91 -0.84% 0.0% 870K
|
Health Services
|
| O: 0.31%
H: 1.75%
C: 1.07%
test drug diagnostics positive diagnostic
Aptevo Therapeutics Reports Positive Phase 1 Clinical Data for Its Lead Leukemia Drug Candidate APVO436 in Adults With Relapsed Acute Myeloid Leukemia
Published: 2021-05-26 (Crawled : 13:15) - biospace.com/
APVO 3 d | $0.77 8.07% 6.25% 210K
|
Health Technology
|
| O: 8.87%
H: 9.09%
C: -8.0%
myeloid leukemia phase 1 positive drug leukemia phase 3 phase 2 apvo436 acute myeloid leukemia
Novel Anti-Cancer Drugs Permeate the Marketplace
Published: 2021-05-25 (Crawled : 13:15) - prnewswire.com
VSTM | $10.23 -5.63% -6.38% 67K
|
Health Technology
|
| O: 0.0%
H: 1.76%
C: -2.76%
SRNE | $0.024 -14.29% -8.85% 57K
|
Health Technology
|
| O: 0.7%
H: 3.18%
C: -2.35%
IMGN | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -4.69%
cancer drug
Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN2A-DEE
Published: 2021-04-30 (Crawled : 13:15) - globenewswire.com
PRAX | $46.59 -8.25% -8.93% 200K
|
Health Technology
|
| O: -2.42%
H: 1.4%
C: -2.48%
treatment drug designation
Merck Drops $425 Million COVID-19 Drug, Refocusing on Another Candidate
Published: 2021-04-15 (Crawled : 13:15) - biospace.com/
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.5%
H: 1.04%
C: -0.21%
covid drop drug
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.